This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nelesen, R. A. Articles by Ziegler, M. G. Search for Related Content PubMed PubMed Citation Articles by Nelesen, R. A. Articles by Ziegler, M. G.

Circulation, Vol 86, 463-466, Copyright © 1992 by American Heart Association

ARTICLES

Plasma atrial natriuretic peptide is unstable under most storage conditions

RA Nelesen, JE Dimsdale and MG Ziegler
Department of Psychiatry, University of California San Diego, La Jolla 92093-0804.

BACKGROUND. Atrial natriuretic peptide (ANP) is a hormonal regulator of cardiovascular fluid volume. More than 1,000 scientific articles were written about ANP between 1987 and 1991. Because some articles hinted at problems with storing ANP, this study examined the effect of numerous techniques for storing and processing human ANP samples. METHODS AND RESULTS. Samples were obtained repeatedly from three patients, treated, and stored under a variety of conditions. Experiment 1 evaluated the effects of different preservatives at 35, 21, 14, 10, and 7 days before assay. Experiment 2 evaluated nonspecific binding of ANP to different storage tubes during 28 days of storage. Experiment 3 evaluated the effect of storage at -20 degrees C, -80 degrees C, and - 196 degrees C for 1 month. ANP was very unstable, degrading as much as 30% after 3 days of storage and by more than 50% in 1 month even when stored at -80 degrees C. Only storage at -196 degrees C (in liquid nitrogen) kept ANP stable for 1 month. Extraction and lyophilization of the samples before freezing and assay within 7 days of freezing only partially minimized the amount of degradation. All other processing techniques had little effect on slowing the degradation of ANP. CONCLUSIONS. These findings raise disturbing questions about the interpretation of the substantial literature on ANP.

This article has been cited by other articles:

				H. Hosoda, K. Doi, N. Nagaya, H. Okumura, E. Nakagawa, M. Enomoto, F. Ono, and K. Kangawa Optimum Collection and Storage Conditions for Ghrelin Measurements: Octanoyl Modification of Ghrelin Is Rapidly Hydrolyzed to Desacyl Ghrelin in Blood Samples Clin. Chem., June 1, 2004; 50(6): 1077 - 1080. [Full Text] [PDF]

				A. M. Richards, R. Doughty, M. G. Nicholls, S. Macmahon, H. Ikram, N. Sharpe, E. A. Espiner, C. Frampton, and T. G. Yandle Neurohumoral Prediction of Benefit From Carvedilol in Ischemic Left Ventricular Dysfunction Circulation, February 16, 1999; 99(6): 786 - 792. [Abstract] [Full Text] [PDF]

				R. O. Bonow New Insights Into the Cardiac Natriuretic Peptides Circulation, June 1, 1996; 93(11): 1946 - 1950. [Full Text]

				H. B. Simon Patient-Directed, Nonprescription Approaches to Cardiovascular Disease Arch Intern Med, October 24, 1994; 154(20): 2283 - 2296. [Abstract] [PDF]